PremiumCompany AnnouncementsPYC Therapeutics Announces Quotation of New Securities on ASX PYC Therapeutics Secures $146 Million in Entitlement Offer to Advance RNA Therapies PYC Therapeutics Advances PYC-003 in Polycystic Kidney Disease Trial PremiumCompany AnnouncementsPYC Therapeutics Releases Interim Financial Statements and Reinforces Commitment to RNA Therapies PYC Therapeutics Expands Market Presence with New Securities Quotation PYC Therapeutics Launches $146 Million Entitlement Offer PremiumCompany AnnouncementsPYC Therapeutics to Issue 116.6 Million Securities in Accelerated Offer PYC Therapeutics Launches Equity Raising to Bolster Financial Position PYC Therapeutics to Raise $146 Million for Drug Pipeline Advancement